TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
IDL Biotech AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,874
|
3,307
|
2,239 |
| Financial expenses |
1
|
1
|
0 |
| Earnings before taxes |
-432
|
22
|
-1,245 |
| EBITDA |
-334
|
295
|
-1,203 |
| Total assets |
3,041
|
3,616
|
4,040 |
| Current assets |
2,380
|
2,973
|
3,440 |
| Current liabilities |
728
|
878
|
596 |
| Equity capital |
2,305
|
2,730
|
3,435 |
| - share capital |
2,273
|
2,267
|
2,466 |
| Employees (average) |
23
|
20
|
16 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
75.8%
|
75.5%
|
85.0% |
| Turnover per employee |
168
|
165
|
140 |
| Profit as a percentage of turnover |
-11.2%
|
0.7%
|
-55.6% |
| Return on assets (ROA) |
-14.2%
|
0.6%
|
-30.8% |
| Current ratio |
326.9%
|
338.6%
|
577.2% |
| Return on equity (ROE) |
-18.7%
|
0.8%
|
-36.2% |
| Change turnover |
558
|
1,249
|
112 |
| Change turnover % |
17%
|
61% | |
| Chg. No. of employees |
3
|
4
|
-2 |
| Chg. No. of employees % |
15%
|
25% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.